The search for inhibitors of Wnt pathway activity in colon cancer cells bearing APC mutations is guided by the concept that only treatments which affect components of the Wnt pathway downstream of APC can be efficient [15, 16]. This evidence concerns the gene APC and colonic neoplasm.